OmniAb (OABI) Total Liabilities (2021 - 2026)
OmniAb (OABI) reported Total Liabilities of $31.0 million for Q1 2026, down 5.09% year-over-year from $32.7 million in Q1 2025, and down 8.51% on a QoQ basis from $33.9 million in Q4 2025.
OmniAb (OABI) has 6 years of Total Liabilities data on file, last reported at $31.0 million in Q1 2026.
- Quarterly Total Liabilities fell 5.09% year-over-year to $31.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.0 million (down 5.09% YoY) and the FY2025 annual result came in at $33.9 million, down 10.68% from the prior year.
- Total Liabilities eased to $31.0 million in Q1 2026 per OABI's latest filing, from $33.9 million in the prior quarter.
- Across five years, Total Liabilities topped out at $79.8 million in Q4 2022 and bottomed at $13.5 million in Q1 2022.
- The 5-year median for Total Liabilities is $37.9 million (2024), against an average of $42.9 million.
- The widest annual swing landed in 2022, when Total Liabilities jumped 78602.45%; it then tumbled 40.7% in 2024.
- Tracing OABI's Total Liabilities over 5 years: stood at $79.8 million in 2022, then retreated by 24.05% to $60.6 million in 2023, then plunged by 37.43% to $37.9 million in 2024, then retreated by 10.68% to $33.9 million in 2025, then declined by 8.51% to $31.0 million in 2026.
- Per Business Quant, the three latest OABI Total Liabilities figures stand at $31.0 million (Q1 2026), $33.9 million (Q4 2025), and $32.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | 31.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.00 Mn |
| Dec 31, 2025 | 33.89 Mn |
| Sep 30, 2025 | 32.25 Mn |
| Jun 30, 2025 | 33.61 Mn |
| Mar 31, 2025 | 32.67 Mn |
| Dec 31, 2024 | 37.94 Mn |
| Sep 30, 2024 | 39.83 Mn |
| Jun 30, 2024 | 43.08 Mn |
| Mar 31, 2024 | 51.16 Mn |
| Dec 31, 2023 | 60.64 Mn |
| Sep 30, 2023 | 67.16 Mn |
| Jun 30, 2023 | 71.43 Mn |
| Mar 31, 2023 | 72.24 Mn |
| Dec 31, 2022 | 79.84 Mn |
| Sep 30, 2022 | 14.29 Mn |
| Jun 30, 2022 | 15.03 Mn |
| Mar 31, 2022 | 13.51 Mn |
| Dec 31, 2021 | 70.16 Mn |
| Sep 30, 2021 | 8.15 Mn |
| Jun 30, 2021 | 618,386.00 |
| Mar 31, 2021 | -17,214.00 |